References
- Willer CJ, Dyment DA, Risch NJ, Sadovnick AD, Ebers GC; Canadian Collaborative Study Group. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc. Natl Acad. Sci. USA 100(22), 12877–12882 (2003).
- Barcellos LF, Oksenberg JR, Begovich AB et al.; Multiple Sclerosis Genetics Group. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am. J. Hum. Genet. 72(3), 710–716 (2003).
- Hafler D, Compston A, Sawcer S et al. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357(9), 851–862 (2007).
- Burton PR, Clayton DG, Cardon LR et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat. Genet. 39(11), 1329–1337 (2007).
- Sawcer S, Hellenthal G, Pirinen M et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476(7359), 214–219 (2011).
- Jafari N, Broer L, van Duijn CM, Janssens AC, Hintzen RQ. Perspectives on the use of multiple sclerosis risk genes for prediction. PLoS ONE 6(12), e26493 (2011).
- Jostins L, Ripke S, Weersma RK et al.; International IBD Genetics Consortium (IIBDGC). Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491(7422), 119–124 (2012).
- Nelson MR, Wegmann D, Ehm MG et al. An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people. Science 337(6090), 100–104 (2012).
- Ramagopalan SV, Dyment DA, Cader MZ et al. Rare variants in the CYP27B1 gene are associated with multiple sclerosis. Ann. Neurol. 70(6), 881–886 (2011).
- Dyment DA, Cader MZ, Chao MJ et al. Exome sequencing identifies a novel multiple sclerosis susceptibility variant in the TYK2 gene. Neurology 79(5), 406–411 (2012).
- Dyment DA, Herrera BM, Cader MZ et al. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum. Mol. Genet. 14(14), 2019–2026 (2005).
- Handel AE, Ramagopalan SV. Concealed effects of gene-environment interactions in genome-wide association. Mult. Scler. Rel. Disord. 1(1), 39–42 (2012).
- Sundqvist E, Sundström P, Lindén M et al. Epstein–Barr virus and multiple sclerosis: interaction with HLA. Genes Immun. 13(1), 14–20 (2012).
- De Jager PL, Chibnik LB, Cui J et al.; Steering Committee of the BENEFIT study; Steering Committee of the BEYOND study; Steering Committee of the LTF study; Steering Committee of the CCR1 study. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. Lancet Neurol. 8(12), 1111–1119 (2009).
- Hedström AK, Sundqvist E, Bäärnhielm M et al. Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. Brain 134(Pt 3), 653–664 (2011).
- Ebers GC, Sadovnick AD, Dyment DA, Yee IM, Willer CJ, Risch N. Parent-of-origin effect in multiple sclerosis: observations in half-siblings. Lancet 363(9423), 1773–1774 (2004).
- Fraga MF, Ballestar E, Paz MF et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl Acad. Sci. USA 102(30), 10604–10609 (2005).
- Baranzini SE, Mudge J, van Velkinburgh JC et al. Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis. Nature 464(7293), 1351–1356 (2010).